| Old Articles: <Older 17001-17010 Newer> |
|---|
 |
The Motley Fool
September 22, 2006
Rick Aristotle Munarriz |
Trade Stocks for Free! Nascent financial site Zecco.com promises to launch a fee-free trading platform. This could be revolutionary. Then again, this could also be a non-event. Investors, take note.   |
The Motley Fool
September 22, 2006
Jeff Hwang |
Fight Night Restarts Ameristar St. Charles The new conference center is just the beginning of Phase 2 for Ameristar Casino's flagship property. Investors, take note. |
The Motley Fool
September 22, 2006
Rich Smith |
Silicon Stays Strong Yesterday, as both the Nasdaq and Dow closed down 0.7% for the day, communications chipmaker Silicon Laboratories issued an earnings warning, but closed the day down less than 0.4%. What gives? |
The Motley Fool
September 22, 2006
Tom Taulli |
Riverbed Goes Upstream The new IPO is addressing a huge market opportunity, but at the current valuation, it's probably better to wait before investing. |
Wall Street & Technology
September 18, 2006 |
Ask The Experts: Mark Madoff, Codirector of Trading at Bernard L. Madoff Investment Securities The battle between Nasdaq and the NYSE is not your traditional price war, which usually is characterized by lower fees. So, how will this price war change order flow, and how will it impact regional exchanges and ECNs? |
BusinessWeek
October 2, 2006
Gene G. Marcial |
Shopping For Schering? The buzz about Schering-Plough on Wall Street is that the company is in play. |
BusinessWeek
October 2, 2006
Gene G. Marcial |
Cleaning Up At Newell Rubbermaid After several years of disappointing results, Newell Rubbermaid is finally winning the Street's favor. |
BusinessWeek
October 2, 2006
Gene G. Marcial |
A Shot In The Arm For Cleveland BioLabs Cleveland Clinic Foundation, famous for treating heart ailments and cancer, has joined forces with Cleveland BioLabs, which received exclusive rights to its cancer and molecular genetic technology. |
The Motley Fool
September 21, 2006
Vitaliy Katsenelson |
Don't Hit the Panic Button Just Yet Wall Street plays the overreacting game; Walgreen and CVS suffer. These stocks have big tailwinds behind them. |
The Motley Fool
September 21, 2006
David Meier |
Darden's Uses of Cash: Fool by Numbers The restaurant operator released first-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
| <Older 17001-17010 Newer> Return to current articles. |
